Cogent Biosciences, Inc. Common Stock (COGT) is a publicly traded Healthcare sector company. As of September 20, 2026, COGT trades at $32.14 with a market cap of $5.47B and a P/E ratio of -14.88. COGT moved -5.12% today. Year to date, COGT is -11.32%; over the trailing twelve months it is +147.64%. Its 52-week range spans $3.72 to $43.73. Analyst consensus is strong buy with an average price target of $54.14. Rallies surfaces COGT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks COGT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $32.14 |
| Market Cap | $5.47B |
| P/E Ratio | -14.88 |
| EPS | $-2.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $43.73 |
| 52-Week Low | $3.72 |
| Volume | 2.71M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-328.94M |
| Gross Margin | 0.00% |
8 analysts cover COGT: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $54.14.